Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Shelburne Group is a private advisory and consulting firm focused on the biotechnology, medical device, and pharmaceutical sectors. The company appears to provide international government relations, market entry, regulatory affairs, stakeholder engagement, and partner development services rather than developing its own therapeutic products. Publicly available information indicates the firm serves life science clients from a base in Bozeman, Montana and is led by founder Greg Meiselbach. Based on the available evidence, it is best characterized as a healthcare-focused consulting business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Shelburne Group.